Cholesteatoma in the pediatric age group.
The diagnosis and management of cholesteatoma in children remains controversial. In the past 15 years, the senior author (S.C.P.) has treated 320 patients with cholesteatoma. Patients 18 years and younger composed 40% (125) of the overall group and are the basis for this report. The patient data were compiled using the history, physical examination, audiograms, radiographs, patient questionnaires, surgical findings, and postoperative observations. The surgical treatment selected was determined by the extent of disease, the configuration of the mastoid, and a clinical assessment of eustachian tube function. A middle ear tympanotomy approach was used in 17% of the patients, a canal wall up procedure in 31%, and a canal wall down procedure in 52.3%. The average clinical follow-up was 3.9 years, with the range being from 3 months to 13.5 years. Hearing was maintained or slightly improved in a majority of cases. Residual disease occurred in 8% of patients, and recurrent disease in only 3%.
Edelstein
D R
DR
Department of Otolaryngology-Head and Neck Surgery, Manhattan Eye, Ear and Throat Hospital, New York, NY 10021.
Parisier
S C
SC
Ahuja
G S
GS
Juarbe
C
C
Chute
P
P
Wenig
S
S
Kaye
S M
SM
D000293:Adolescent; D000367:Age Factors; D001844:Bone Conduction; D002648:Child; D002675:Child, Preschool; D002781:Cholesteatoma / Q000150:complications / Q000503:physiopathology / Q000601:surgery*; D004427:Ear Diseases / Q000150:complications / Q000503:physiopathology / Q000601:surgery; D004429:Ear Ossicles / Q000601:surgery; D004432:Ear, Middle; D005260:Female; D006309:Hearing; D006801:Humans; D008297:Male; D012008:Recurrence; D012189:Retrospective Studies; D013997:Time Factors; D014433:Tympanoplasty